Officers of the Board
|
| Chair |
Alastair Kent, EGAN (European Genetic Alliances’ Network) |
| Chair-elect |
Andrea Rappagliosi (GlaxoSmithKline) |
| Acting Treasurer |
Rod Mitchell (independent) |
| Secretary |
Helena Kääriäinen, ESHG (European Society of Human Genetics) |
| |
|
Board Members
|
| Academic Sciences |
Industry |
Patients’ Organisations |
|
Helena Kääriäinen
National Insitutue for Health & Welfare (Finland) and ESHG (European Society of Human Genetics)
|
Emmanuel Chantelot
Shire
|
Koen Block
EATG (European AIDS Treatment Group) |
|
Bernard Maillet
UEMS (Union of European Medical Specialists)
|
Andrea Rappagliosi
GlaxoSmithKline |
Alastair Kent
EGAN (European Genetics Alliances' Network)
|
| |
Detlef Niese
Novartis |
Erik Briers
EuropaUomo (Prostate Cancer Coalition) |
| |
Nathalie Stieger
F Hoffmann-La Roche |
Dolores Gauci
GAMIAN Europe (Global Alliance of Mental Illness Advocacy Networks - Europe) |
| |
Miriam Gargesi
EDMA (European Diagnostic Manufacturers Association)
|
Yann Le Cam
EURORDIS (European Rare Diseases)
|
| |
Graeme Holland
GE Healthcare
|
Lynne van Poelgeest-Pomfret
WFIP (World Federation of Incontinence Patients)
|
|
|
Epposi Board
